QUALITY of lifePSYCHOLOGICAL factorsSEVERITY of illness indexSYMPTOMSBackground/Aim. Psoriasis is a chronic multisystem, inflammatory, and immune-mediated dermatological disease of a relapsing nature. Not only does it affect objective parameters such as skin and joints, with different intensi...
Bilgic A, Bilgic O, Akis HK, Eskioğlu F, Kılıç EZ (2010) Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis. Pediatr Dermatol 27:614–617 Article PubMed Google Scholar Boccardi D, Menni S, La Vecchia C, Nobile M, Decarli A, ...
Gustav Schelling et al., “Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome”, Critical Care Medicine, Issue: vol. 26(4), pp. 651-659, Apr. 1998. Hanna Schierbeck et al., “Immunomodulatory Drugs Regulate HMGB1 Release...
Background Treatment with anti-TNF drugs in psoriasis arthritis (PsA) have in several randomized studies shown to have a favorable effect by reducing signs and symptoms and reducing the rate of radiographic progression (ref.1,2). However... G Haugeberg,AM Gulati,AP Diamantopoulos,... - 《Ann...
Early detection of psychological vulnerability in patients with psoriasis seems to be of great clinical importance and significantly impacts the quality of life of the patients. Objectives: We sought to clarify the association between psoriasis and depressive symptoms in patients with moderate to severe ...
The bimekizumab data presented at EADV 2024 showed maintained improvements in clinical response, symptoms, severity, and quality of life over two years. These findings are particularly encouraging given the need for new treatment options that offer sustained relief for patients," ...
Ixekizumab improves disease severity, clinical symptoms and quality of life in patients with genital psoriasis: a 24-week real-life experience assess real-life effectiveness and safety of ixekizumab in the treatment of GenPs in a case series of patients with moderate-to-severe plaque psoriasis. ....
Waldman Department of Dermatology. Psoriasis affects more than 7.5 million adults in the U.S. and impacts much more than the skin itself.5 In addition to the recognized skin symptoms such as itching and flaking, psoriasis can place strains on patients a...
In clinical trials, subcutaneous secukinumab was more effective than placebo, etanercept and ustekinumab at improving both psoriasis symptoms (with high skin clearance) and health-related quality of life. Moreover, secukinumab was more effective than placebo in the difficult-to-treat palmoplantar and ...
Waldman Department of Dermatology. Psoriasis affects more than 7.5 million adults in the U.S. and impacts much more than the skin itself.5 In addition to the recognized skin symptoms such as itching and flaking, psoriasis can place strains on patients and...